Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Tulalamba, Warut [VerfasserIn]   i
 Weinmann, Jonas [VerfasserIn]   i
 El Andari, Jihad [VerfasserIn]   i
 Grimm, Dirk [VerfasserIn]   i
Titel:Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors
Verf.angabe:Warut Tulalamba, Jonas Weinmann, Quang Hong Pham, Jihad El Andari, Thierry VandenDriessche, Marinee K. Chuah, Dirk Grimm
Jahr:2020
Jahr des Originals:2019
Umfang:10 S.
Fussnoten:Gesehen am 17.04.2020 ; Published online: 17 October 2019
Titel Quelle:Enthalten in: Gene therapy
Ort Quelle:London : Nature Publ. Group, 1997
Jahr Quelle:2020
Band/Heft Quelle:27(2020), 3-4, Seite 170-179
ISSN Quelle:1476-5462
Abstract:The human musculature is a promising and pivotal target for human gene therapy, owing to numerous diseases that affect this tissue and that are often monogenic, making them amenable to treatment and potentially cure on the genetic level. Particularly attractive would be the possibility to deliver clinically relevant DNA to muscle tissue from a minimally invasive, intravenous vector delivery. To date, this aim has been approximated by the use of Adeno-associated viruses (AAV) of different serotypes (rh.74, 8, 9) that are effective, but unfortunately not specific to the muscle and hence not ideal for use in patients. Here, we have thus studied the muscle tropism and activity of another AAV serotype, AAVpo1, that was previously isolated from pigs and found to efficiently transduce muscle following direct intramuscular injection in mice. The new data reported here substantiate the usefulness of AAVpo1 for muscle gene therapies by showing, for the first time, its ability to robustly transduce all major muscle tissues, including heart and diaphragm, from peripheral infusion. Importantly, in stark contrast to AAV9 that forms the basis for ongoing clinical gene therapy trials in the muscle, AAVpo1 is nearly completely detargeted from the liver, making it a very attractive and potentially safer option.
DOI:doi:10.1038/s41434-019-0106-3
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.1038/s41434-019-0106-3
 Volltext: https://www.nature.com/articles/s41434-019-0106-3
 DOI: https://doi.org/10.1038/s41434-019-0106-3
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:cardiac gene-transfer
 efficacy
 factor-ix
 hemophilia
 hepatocytes
 pompe-disease
 responses
 skeletal-muscle
 therapy
 virus serotype-9 leads
K10plus-PPN:1694846628
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68565798   QR-Code
zum Seitenanfang